Hyperlipoproteinemia Type I: Disease Bioinformatics
Research of Hyperlipoproteinemia Type I has been linked to Hyperlipoproteinemias, Hyperlipidemia, Pancreatitis, Hyperlipoproteinemia Type Iv, Diabetes Mellitus. The study of Hyperlipoproteinemia Type I has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Hyperlipoproteinemia Type I include Secretion, Transport, Pathogenesis, Insulin Secretion, Platelet Aggregation. These pathways complement our catalog of research reagents for the study of Hyperlipoproteinemia Type I including antibodies and ELISA kits against LPL, LCP1, VLDL, INS, APOC2.
Hyperlipoproteinemia Type I Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hyperlipoproteinemia Type I below!
For more information on how to use Laverne, please read the How to Guide.
We have 2069 products for the study of Hyperlipoproteinemia Type I that can be applied to Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
Hyperlipoproteinemia Type I is also known as Burger-grutz Syndrome, Deficiency, Lipoprotein Lipase, Endogenous Hypertriglyceridaemia, Endogenous Hypertriglyceridemia, Essential Familial Hyperlipemia.